finance
Law Firm Files Securities-Fraud Class Action Lawsuit Against GeneDx Holdings
Kessler Topaz Meltzer & Check, LLP filed a class action alleging securities fraud on behalf of investors who bought GeneDx Holdings Corp. stock between April 16, 2025, and May 4, 2026.
Jun 18, 5:30 PM·1m read1 source
benzinga.comAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
Kessler Topaz Meltzer & Check, LLP filed a securities fraud class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS) in the United States District Court for the District of Connecticut. The suit is captioned Taher Basma v.
No. 26-cv-00880. It covers investors who purchased or acquired the company's common stock between April 16, 2025, and May 4, 2026, inclusive. provides genetic testing services for diagnosing pediatric and rare diseases.
Attorney Jonathan Naji, Esq. of Kessler Topaz Meltzer & Check, LLP is the listed contact for investors seeking to discuss their legal rights. Benzinga reported the filing of the complaint.
Transparency
How sources framed this
Single source — no framing comparison available.
CorroborationLimited · 1 source
